Literature DB >> 3991567

The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria.

E van Ballegooie, P E de Jong, A J Donker, W J Sluiter.   

Abstract

The effect of continuous subcutaneous insulin infusion on renal function was studied in 12 patients with insulin-dependent diabetes mellitus. Serum creatinine was less than 110 mumol/L in all patients. Total urinary protein excretion was less than 250 mg/24 hr in seven patients (group I) and exceeded 0.5 g/24 hr in five (group II). Initial glomerular filtration rate was higher in group I compared with group II: 136.0 +/- 8.5 ml/min versus 103.2 +/- 4.6 ml/min (mean +/- SEM; p less than 0.02). After one to three months pump therapy glomerular filtration rate decreased in both groups. It remained stable during 32-36 months in group I (126.3 +/- 6.1, and 127.9 +/- 7.7 ml/min, respectively) but deteriorated in group II (98.6 +/- 4.4, and 60.0 +/- 6.8 ml/min, respectively; p less than 0.01 compared with group I). These results indicate that strict blood glucose control with continuous subcutaneous insulin infusion does not prevent deterioration of renal function in type I diabetic patients with clinical proteinuria. This suggests that other factors than metabolic control are involved in the course of diabetic nephropathy.

Entities:  

Mesh:

Year:  1985        PMID: 3991567

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc Eur Ren Assoc


  2 in total

1.  Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

Authors:  Jan Skupien; James H Warram; Adam Smiles; Andrzej Galecki; Robert C Stanton; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

2.  The effect of low-dose dopamine on renal haemodynamics in patients with type 1 (insulin-dependent) diabetes does not differ from normal individuals.

Authors:  P M ter Wee; E van Ballegooie; J B Rosman; S Meijer; A J Donker
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.